Gortune Investment

Gortune Investment is a private investment company established in 2016 and based in Guangzhou, China. Initiated by the Guangdong provincial government alongside several large private enterprises, it operates as both a venture capital and asset management firm. The company focuses on investing in a diverse range of sectors, including education, healthcare, food, environmental protection, new energy, artificial intelligence, and advanced manufacturing. Through its strategic investments, Gortune aims to contribute to the development and modernization of these industries in China.

Junying Ye Ph.D

Chairman and President

7 past transactions

Maxvax Health

Series B in 2022
Maxvax Health is a biotechnology company focused on the development and commercialization of innovative vaccines. The company specializes in vaccine technology targeting viral diseases, including rotavirus, shingles, and herpes. By advancing these vaccines, Maxvax Health aims to enhance treatment options for healthcare professionals and improve patient outcomes. Through its efforts in vaccine development, the company seeks to address significant health challenges posed by viral infections.

Porton Advanced Solutions

Series B in 2022
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.

Wensheng AMC

Private Equity Round in 2022
Wensheng AMC is a company that specializes in investment and management services focused on special opportunities within the financial sector. Its core business includes the investment in non-performing assets and the management of these investments to facilitate recovery and value enhancement. Additionally, Wensheng AMC offers restructuring services for distressed enterprises and real estate, as well as investments in defaulted bonds. By providing these services, the company aims to help clients capitalize on unique investment opportunities and improve the financial performance of troubled assets.

Canton Biologics

Angel Round in 2018
Canton Biologics is a contract development and manufacturing organization based in China that specializes in the research and development of biologic drugs. The company offers a range of services tailored for the biopharmaceutical industry, including clinical and commercial production. Canton Biologics focuses on the development and production of biomacromolecule drugs, such as monoclonal antibodies, double antibodies, fusion proteins, and recombinant proteins. With a commitment to advancing biologic drug development, Canton Biologics plays a pivotal role in supporting the needs of biopharma companies and contract research organizations.

Ping An Good Doctor

Series F in 2018
Ping An Health Internet is a wholly owned subsidiary of China Ping An Group, an important member of the Internet business segment/. It was established in August 2014 with 350 million yuan registered capital and is headquartered in Shanghai, China. Companies around the network of doctors, drug network and information network formed three product lines, involving online inquiry, a plurality of segments of the doctor-patient health care management, drug O2O, electronic health records, chronic disease management, child health services. Chinese company to the mobile Internet era medical wisdom of the leader as the goal, to create a user-stop health management solutions provider, China's largest Internet to build a healthy industry ecosystem. Ping An Health Internet also developed a children's health management and chronic disease management, and other vertical applications, to meet the needs of market segments. Reform the health care system combined with the trend, the company vigorously promote the integration of physician resources.

Dianmi Technology

Series A in 2017
Dianmi Technology, established in 2015, is a leading provider of human resources technology and services in China. The company offers a comprehensive range of human resources solutions, including personnel agency, outsourcing services, labor dispatch, payroll services, and human resources legal affairs. With service outlets spanning 241 cities and regions across the country, Dianmi Technology manages and services over 130,000 employees. Additionally, the company develops human resources management software that assists organizations in managing employee onboarding and exit processes, insurance contributions, benefits, and performance measurement, enabling enterprises to implement standardized HR practices effectively.

Zhongke Zidong Taichu

Zhongke Zidong Taichu develops and applies general artificial intelligence to accelerate the conversion of scientific and technological advances into usable productivity. The company designs and provides AI agents for content creation and analysis across text, music, photos, and videos, and concentrates on 3D sensing, radar signal analysis, and big data to empower users with capable AI tools that address complex problems.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.